INFLUENZA
Clinical trials for INFLUENZA explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA trials appear
Sign up with your email to follow new studies for INFLUENZA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New flu vaccine candidate heads into first human tests
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial compares an experimental flu vaccine (H1ssF) with the standard seasonal flu shot (Flucelvax) in 112 adults aged 18-70. Some participants have had flu shots before, while others have never been vaccinated. The main goal is to check safety and how the immune …
Matched conditions: INFLUENZA
Phase: PHASE1 • Sponsor: University of Minnesota • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 02:06 UTC
-
New flu vaccine trial aims to boost protection
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial tests a new flu vaccine with an added ingredient (BK-01 adjuvant) to see if it is safe and triggers a strong immune response. About 160 adults aged 18 and older will receive either the new vaccine, a standard flu vaccine, or a placebo. Participants will be …
Matched conditions: INFLUENZA
Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:41 UTC
-
New pill aims to stop flu before it starts
Disease control Not yet recruitingThis study tests whether a new oral drug, TRX-100, can prevent flu infection in healthy adults aged 18-55. Participants will be exposed to the flu virus and monitored for symptoms and viral levels. The goal is to see if the drug is safe and effective at stopping the flu from taki…
Matched conditions: INFLUENZA
Phase: PHASE2 • Sponsor: Traws Pharma, Inc. • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Can steroids save lives in severe flu pneumonia? major trial launches
Disease control Not yet recruitingThis study tests whether adding corticosteroids to standard care can lower the risk of death in adults with severe flu pneumonia in the ICU. About 496 participants will receive either standard care alone or standard care plus different doses of steroids. The goal is to find a saf…
Matched conditions: INFLUENZA
Phase: PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New flu shot for seniors put to the test
Prevention Not yet recruitingThis study tests a new flu vaccine in 1200 adults aged 60 and older. Participants will receive either the new vaccine or a standard flu shot. Researchers will check how well the vaccine boosts immunity and monitor for any side effects over 30 days.
Matched conditions: INFLUENZA
Phase: PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Prevention
Last updated May 17, 2026 02:04 UTC
-
Could a simple nasal device stop COVID and flu?
Prevention Not yet recruitingThis study tests whether using two nasal protective devices together can lower the chance of getting respiratory infections like COVID-19 and the flu. About 2000 adults will use the devices in daily life for 8 weeks. The study also checks how easy they are to use and if they caus…
Matched conditions: INFLUENZA
Phase: NA • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Prevention
Last updated Apr 29, 2026 15:05 UTC
-
New flu pill for teens aims to knock out symptoms faster
Symptom relief Not yet recruitingThis study tests whether a new antiviral pill, onradivir, can help teenagers aged 12 to 17 recover faster from the flu. About 150 teens with uncomplicated influenza A will take either the medicine or a placebo once daily for five days. Researchers will track how quickly symptoms …
Matched conditions: INFLUENZA
Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated May 17, 2026 02:02 UTC
-
Scientists to map brain changes in people with smell disorders
Knowledge-focused Not yet recruitingThis study looks at how the brain works differently in people with smell problems caused by things like infections or injuries. Researchers will use brain scans, smell tests, and questionnaires to track changes over one year. 80 adults (including healthy volunteers) will take par…
Matched conditions: INFLUENZA
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Boosting flu shots: Follow-Up study tests Supplement's staying power
Knowledge-focused Not yet recruitingThis follow-up study looks at whether a supplement called TUDCA can help the flu vaccine work longer in adults aged 60-70. Participants from an earlier study will give one blood sample about 8 months after their flu shot to measure antibody levels and immune memory cells. No new …
Matched conditions: INFLUENZA
Sponsor: Tsinghua University • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC